- Home
- REFI vs ZURA Comparison
REFI vs ZURA Comparison
Compare REFI & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REFI
- ZURA
- Stock Information
- Founded
- REFI 2021
- ZURA 2022
- Country
- REFI United States
- ZURA United States
- Employees
- REFI N/A
- ZURA N/A
- Industry
- REFI Real Estate Investment Trusts
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- REFI Real Estate
- ZURA Health Care
- Exchange
- REFI Nasdaq
- ZURA Nasdaq
- Market Cap
- REFI 306.1M
- ZURA 292.1M
- IPO Year
- REFI 2021
- ZURA N/A
- Fundamental
- Price
- REFI $16.20
- ZURA $2.66
- Analyst Decision
- REFI Strong Buy
- ZURA Buy
- Analyst Count
- REFI 3
- ZURA 6
- Target Price
- REFI $20.00
- ZURA $15.80
- AVG Volume (30 Days)
- REFI 118.5K
- ZURA 611.9K
- Earning Date
- REFI 11-07-2024
- ZURA 11-07-2024
- Dividend Yield
- REFI 11.63%
- ZURA N/A
- EPS Growth
- REFI N/A
- ZURA N/A
- EPS
- REFI 2.00
- ZURA N/A
- Revenue
- REFI $56,860,278.00
- ZURA N/A
- Revenue This Year
- REFI N/A
- ZURA N/A
- Revenue Next Year
- REFI $4.27
- ZURA N/A
- P/E Ratio
- REFI $8.08
- ZURA N/A
- Revenue Growth
- REFI 6.49
- ZURA N/A
- 52 Week Low
- REFI $14.82
- ZURA $2.00
- 52 Week High
- REFI $17.65
- ZURA $6.35
- Technical
- Relative Strength Index (RSI)
- REFI 56.28
- ZURA 39.80
- Support Level
- REFI $15.69
- ZURA $2.16
- Resistance Level
- REFI $16.24
- ZURA $2.50
- Average True Range (ATR)
- REFI 0.20
- ZURA 0.26
- MACD
- REFI -0.02
- ZURA 0.04
- Stochastic Oscillator
- REFI 79.03
- ZURA 33.33
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.
About ZURA Zura Bio Limited
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.